CSPC Innovation: Commercialization-related work for ustekinumab injection is proceeding in an orderly manner.

CSPC Innovation stated on the interactive platform on October 4 in response to investors that the company's commercialization-related work for ustekinumab injection is progressing in an orderly manner, and the relevant progress shall be subject to official public disclosures and company announcements.